JP2022543960A5 - - Google Patents

Info

Publication number
JP2022543960A5
JP2022543960A5 JP2021572488A JP2021572488A JP2022543960A5 JP 2022543960 A5 JP2022543960 A5 JP 2022543960A5 JP 2021572488 A JP2021572488 A JP 2021572488A JP 2021572488 A JP2021572488 A JP 2021572488A JP 2022543960 A5 JP2022543960 A5 JP 2022543960A5
Authority
JP
Japan
Prior art keywords
peptide
cii
drb1
domain
mhc class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021572488A
Other languages
English (en)
Japanese (ja)
Other versions
JP7492538B2 (ja
JP2022543960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072287 external-priority patent/WO2021028350A1/en
Publication of JP2022543960A publication Critical patent/JP2022543960A/ja
Publication of JP2022543960A5 publication Critical patent/JP2022543960A5/ja
Application granted granted Critical
Publication of JP7492538B2 publication Critical patent/JP7492538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021572488A 2019-08-09 2020-08-07 Mhc ii/cii複合体の生成 Active JP7492538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19191094.2 2019-08-09
EP19191094 2019-08-09
PCT/EP2020/072287 WO2021028350A1 (en) 2019-08-09 2020-08-07 Production of mhc ii/cii complexes

Publications (3)

Publication Number Publication Date
JP2022543960A JP2022543960A (ja) 2022-10-17
JP2022543960A5 true JP2022543960A5 (https=) 2023-09-07
JP7492538B2 JP7492538B2 (ja) 2024-05-29

Family

ID=67587675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572488A Active JP7492538B2 (ja) 2019-08-09 2020-08-07 Mhc ii/cii複合体の生成

Country Status (9)

Country Link
US (1) US20220288177A1 (https=)
EP (1) EP4010007B1 (https=)
JP (1) JP7492538B2 (https=)
KR (1) KR102831696B1 (https=)
CN (1) CN114206945B (https=)
CA (1) CA3137810A1 (https=)
ES (1) ES2971719T3 (https=)
PL (1) PL4010007T3 (https=)
WO (1) WO2021028350A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024537611A (ja) * 2021-08-30 2024-10-16 ジェネンテック, インコーポレイテッド Mhciiペプチド結合の性質決定のためのアッセイおよび試薬
CN119630690A (zh) 2022-06-03 2025-03-14 豪夫迈·罗氏有限公司 改进的生产细胞
EP4378533A1 (en) 2022-11-29 2024-06-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Patient selection and therapy monitoring for autoimmune disorders
WO2024117967A1 (en) * 2022-12-01 2024-06-06 Dubnovitsky Anatoly Peptide mimics and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2629881C (en) 2005-11-17 2017-09-12 Rikard Holmdahl A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif
WO2008116468A2 (en) * 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3620465B1 (en) 2007-07-03 2025-02-19 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US9695410B2 (en) * 2010-07-15 2017-07-04 Technion Research & Development Foundation Limited Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
US20130309229A1 (en) 2011-01-28 2013-11-21 The United States Government As Represented By The Department Of Veterans Affairs Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
WO2017106684A2 (en) * 2015-12-17 2017-06-22 Janssen Biotech, Inc. Antibodies specifically binding hla-dr and their uses

Similar Documents

Publication Publication Date Title
JP2022543960A5 (https=)
KR100891509B1 (ko) 연결체들
JP2020500015A5 (https=)
US20040209295A1 (en) Chimeric MHC protein and oligomer thereof
KR101702342B1 (ko) 폴리뉴클레오타이드 및 폴리펩타이드 서열 및 이의 방법
JP2023518434A5 (https=)
JP2892596B2 (ja) ヒト−レラキシン遺伝子
CN107698684B (zh) 包含突变的免疫球蛋白Fc部分的GLP-1融合蛋白
KR101454316B1 (ko) 활성형 TNFR-Fc 융합 단백질을 제조하는 방법
NZ515913A (en) Modified chimeric polypeptides with improved pharmacokinetic properties
WO2009142773A4 (en) Multivalent fibronectin based scaffold domain proteins
CN103874711A (zh) 用于结晶g-蛋白偶联受体目的的新的融合伴体
JPH10501131A (ja) オンコスタチンm受容体
AU1440392A (en) Serine-rich peptide linkers
JP2009537165A5 (https=)
EP2214690B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CN101146818A (zh) 生产分泌性三聚受体类似物和生物活性融合蛋白的方法与组合物
CN108290928B (zh) 卷曲螺旋连接体
RU2000103824A (ru) Адипоцит-специфические белковые гомологи
JP2003506008A5 (https=)
US20210372948A1 (en) Versatile display scaffolds for proteins
CN116836955B (zh) 末端脱氧核苷酸转移酶及其制备方法
JP2002504333A5 (https=)
IE52781B1 (en) Human proinsulin and preproinsulin genes
CA2324513A1 (en) Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production